Interlude
Moderate to Severe Mitral Regurgitation
Sara Olson, RN | sara.olson@allina.com | 612-863-7601
The purpose of this study is to assess the safety and performance of the Caisson Interventional Transcatheter MitralValve Replacement (TMVR) system for the treatment of severe symptomatic MitralValve Regurgitation (MR). This study will provide initial information on the safety and performance of this system.
Mario Goessl, MD
Caisson
Open/Enrolling